Skip to content

Application of digital twin-based robotic rehabilitation technology in patients with motor dysfunction

Application of digital twin-based robotic rehabilitation technology in patients with motor dysfunction

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400093181
Enrollment
Unknown
Registered
2024-11-29
Start date
2024-12-01
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with motor dysfunction

Interventions

Robot group:Digital-twin robot + rehabilitation
Control group (rehabilitation):Rehabilitation

Sponsors

Shanghai Geriatric Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Subjects who meet the diagnosis of "movement disorder", with no limit to disease. 2.The age is 20-80 years old, male or female, left and right. 3.The muscle strength of the upper limbs, hands, and lower limbs on the affected side is at least grade 3. 4.Voluntary participation, no history of mental illness, able to fully understand and cooperate with this experiment, no obvious cognitive deficits and willing to sign the experimental consent form in person or authorized family members. 5.The course of the disease is not limited. 6.There are no serious cardiopulmonary diseases, coagulation disorders, kidney failure, acute stroke, fractures and other serious diseases, and women who are trying to get pregnant or pregnant.

Exclusion criteria

Exclusion criteria: 1.Patients with Parkinson's disease and other diseases that can cause hypertonia, combined with muscle, bone and joint lesions. 2.Those who have severe cognitive, speech, vision, hearing impairment (such as deaf-mute) or mental disorders that affect the examination and treatment; People with claustrophobia. 3.Patients with tumors, severe respiratory, cardiovascular, digestive, urinary, endocrine and hematopoietic system diseases, such as congestive heart failure, uncontrolled hypertension, blood pressure higher than 140/90mmHg, active liver disease, liver and kidney insufficiency. 4.There are contraindications to surface electromyography and gait analysis.

Design outcomes

Primary

MeasureTime frame
Muscle strength;

Secondary

MeasureTime frame
Index on motor function;sEMG;Kinetic analysis;

Countries

China

Contacts

Public ContactYinglun Chen

Shanghai Geriatric Medical Center

chenyl11@foxmail.com+86 21 51371990

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026